Phase 2Completed
Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients
Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Type 2 Diabetes Patients With Poor Blood Glucose Control After Diet and Exercise Intervention: a Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Study
- Sponsor
- Beijing Supreme Life Pharmaceutical Technology Co., Ltd. (Industry)
- Enrolment
- 95 enrolled
- Conditions
- Diabetes Mellitus, Type 2; Diabetes; Type2diabetes
- Interventions
- Fuling Yunhua Granules; Dihuang Baoyuan Granules; Fuling Yunhua Granules matched placebo/Dihuang Baoyuan Granules matched placebo
- Ages
- adults, older adults
- Registry
- NCT06575478
From the registry
The goal of this investigator-initiated clinical trial is to investigate the efficacy and safety of sequential therapy of Fuling Yunhua Granules (prescription A) and Dihuang Baoyuan Granule (prescription B) in the treatment of type 2 diabetes patients with poor glycemic control after diet and exercise intervention.
Primary outcomes
- Change in HbA1c Concentrations (%) From Baseline